Arterial Stiffness in Mild Primary Hyperparathyroidism
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
When primary hyperparathyroidism was a more symptomatic disease, it was often associated with increased cardiovascular risk. As the clinical manifestations of the disease have changed to a milder, more asymptomatic disorder, investigation is shifting to more subtle cardiovascular abnormalities. We measured arterial stiffness in 39 patients with mild primary hyperparathyroidism [serum calcium, 2.66 +/- 0.2 mmol/liter (10.7 +/- 0.6 mg/dl); PTH, 21.7 +/- 9.5 pmol/liter (89 +/- 39 pg/ml)] and in 134 controls. Arterial stiffness was measured mathematically at the radial artery with a noninvasive device as the "augmentation index" (AIx). The AIx measures the difference between the second and first systolic peaks in the pressure waveform and correlates with increased cardiovascular risk. When physiological variables affecting augmentation index and potentially confounding cardiovascular risk factors (age, gender, heart rate, height, blood pressure, diabetes mellitus, smoking, and hyperlipidemia) were adjusted for, primary hyperparathyroidism was an independent predictor of increased augmentation index (B = 3.37; P < 0.03). A matched-pair analysis showed that 15% of the variance in AIx was uniquely accounted for by the presence of primary hyperparathyroidism. The presence of primary hyperparathyroidism was a stronger predictor of elevated AIx than age, gender, smoking, hypertension, hyperlipidemia, or diabetes mellitus. AIx was also directly correlated with evidence of more active parathyroid disease, including higher PTH levels (r = +0.42; P < 0.05) and lower bone mineral density at the distal one-third radius (r = -0.33; P < 0.05). The diagnosis of primary hyperparathyroidism was therefore an independent predictor of increased AIx, an early measure of arterial stiffness, and the increase was associated with evidence of more active parathyroid disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
Pauca, A. L., O’Rourke, M. F., & Kon, N. D. (2001) · Hypertension · doi:10.1161/hy1001.096106 · Cited by 1,179
Effects of age and aerobic capacity on arterial stiffness in healthy adults.
Vaitkevicius, P. V., Fleg, J. L., Engel, J. H., O'Connor, F. C., Wright, J. G., Lakatta, L. E., Yin, F. C., & Lakatta, E. G. (1993) · Circulation · doi:10.1161/01.cir.88.4.1456 · Cited by 1,083 · cited 2×
“In addition, a younger control group was used, in whom the AIx might be lower simply as a function of age (11).”
MethodResultArterial stiffness, wave reflections, and the risk of coronary artery disease
Weber, T., Auer, J., O’Rourke, M. F., Kvas, E., Lassnig, E., Berent, R., & Eber, B. (2004) · Circulation · doi:10.1161/01.cir.0000105767.94169.e3 · Cited by 1,081
Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis
Wilkinson, I. B., Fuchs, S. A., Jansen, I. M., Spratt, J. C., Murray, G. D., Cockcroft, J. R., & Webb, D. J. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816121-00033 · Cited by 924 · cited 1×
“Reproducibility of the AIx using the SphygmoCor apparatus was determined as described previously (22).”
MethodKARAMANOGLU, M., O'ROURKE, M. F., AVOLIO, A. P., & KELLY, R. P. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.2.160 · Cited by 873
Salomaa, V., Riley, W., Kark, J. D., Nardo, C., & Folsom, A. R. (1995) · Circulation · doi:10.1161/01.cir.91.5.1432 · Cited by 582
Arterial Stiffness Increases With Deteriorating Glucose Tolerance Status: The Hoorn Study
Henry, R. M. A., Kostense, P. J., Spijkerman, A. M. W., Dekker, J. M., Nijpels, G., Heine, R. J., Kamp, O., Westerhof, N., Bouter, L. M., & Stehouwer, C. D. A. (2003) · Circulation · doi:10.1161/01.cir.0000065222.34933.fc · Cited by 471 · cited 1×
“Increased AIx occurs in diabetes mellitus and hypercholesterolemia, probably as a result of alterations in the arterial wall elastin and collagen (14, 15).”
BackgroundIncreased central pulse pressure and augmentation index in subjects with hypercholesterolemia
Wilkinson, I. B., Prasad, K., Hall, I. R., Thomas, A., MacCallum, H., Webb, D. J., Frenneaux, M. P., & Cockcroft, J. R. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01723-0 · Cited by 448 · cited 1×
“Increased AIx occurs in diabetes mellitus and hypercholesterolemia, probably as a result of alterations in the arterial wall elastin and collagen (14, 15).”
BackgroundKelly, R. P., Millasseau, S. C., Ritter, J. M., & Chowienczyk, P. J. (2001) · Hypertension · doi:10.1161/01.hyp.37.6.1429 · Cited by 393 · cited 2×
“Other factors that can influence AIx include heart rate and height (9, 10).”
Background
Cited by
Silverberg, S. J., Lewiecki, E. M., Mosekilde, L., Peacock, M., & Rubin, M. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1760 · Cited by 688
Self-citationWalker, M. D., & Silverberg, S. J. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.104 · Cited by 566
Self-citationAmbrogini, E., Cetani, F., Cianferotti, L., Vignali, E., Banti, C., Viccica, G., Oppo, A., Miccoli, P., Berti, P., Bilezikian, J. P., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0219 · Cited by 404
Self-citationSilverberg, S. J., Clarke, B. L., Peacock, M., Bandeira, F., Boutroy, S., Cusano, N. E., Dempster, D., Lewiecki, E. M., Liu, J.-M., Minisola, S., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1415 · Cited by 378
Self-citationBollerslev, J., Jansson, S., Mollerup, C. L., Nordenström, J., Lundgren, E., Tørring, O., Varhaug, J.-E., Baranowski, M., Aanderud, S., Franco, C., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1836 · Cited by 368
“In a recent study of patients with mild pHPT, the diagnosis was associated with increased arterial stiffness (8), but the clinical relevance of these data is not known nor are the effects of successful parathyroid surgery on this parameter.”
BackgroundYiu, Y.-F., Yiu, K.-H., Siu, C.-W., Chan, Y.-H., Li, S.-W., Wong, L.-Y., Lee, S. W. L., Tam, S., Wong, E. W. K., Lau, C.-P., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.013 · Cited by 182
Cardiovascular manifestations of primary hyperparathyroidism: a narrative review
Pepe, J., Cipriani, C., Sonato, C., Raimo, O., Biamonte, F., & Minisola, S. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0485 · Cited by 165
“Mild PHPT “per se” has been considered a stronger predictor of increased aortic stiffness compared to other traditional cardiovascular risk factors being associated with the degree of PTH elevations (69, 70).”
Hypertension in chronic kidney disease: What lies behind the scene
Ameer, O. Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.949260 · Cited by 201
“, 2020), where the PTH itself also directly affects vascular tone (Rubin et al., 2005).”
BackgroundCarotid Vascular Abnormalities in Primary Hyperparathyroidism
Walker, M. D., Fleischer, J., Rundek, T., McMahon, D. J., Homma, S., Sacco, R., & Silverberg, S. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1086 · Cited by 153
“, Santee, CA), which detects PTH (1-84) and PTH (7-84).”
BackgroundSelf-citationNeuropsychological Features in Primary Hyperparathyroidism: A Prospective Study
Walker, M. D., McMahon, D. J., Inabnet, W. B., Lazar, R. M., Brown, I., Vardy, S. B., Cosman, F., & Silverberg, S. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2574 · Cited by 153
Self-citationThe diagnosis and management of asymptomatic primary hyperparathyroidism
Silverberg, S. J., & Bilezikian, J. P. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0265 · Cited by 152
Self-citationEffect of Surgery on Cardiovascular Risk Factors in Mild Primary Hyperparathyroidism
Bollerslev, J., Rosen, T., Mollerup, C. L., Nordenström, J., Baranowski, M., Franco, C., Pernow, Y., Isaksen, G. A., Godang, K., Ueland, T., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2742 · Cited by 150
“Furthermore, arterial stiffness was increased and correlated to disease activity (PTH levels) in mild pHPT (20).”
BackgroundMethodInfluentialEffects of Vitamin D on Cardiovascular Risk and Oxidative Stress
Renke, G., Starling-Soares, B., Baesso, T., Petronio, R., Aguiar, D., & Paes, R. (2023) · Nutrients · doi:10.3390/nu15030769 · Cited by 160
“Indeed, a positive correlation between PTH and aldosterone levels was described in 2009 by Brunaud and colleagues, where several clinical and experimental studies showed that PTH could directly or indirectly stimulate (via the RAAS) the synthesis of mineralocorticoids [54,74,75].”
BackgroundCardiovascular aspects of primary hyperparathyroidism
Walker, M. D., & Silverberg, S. J. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346443 · Cited by 133
Self-citationAldosterone and parathyroid hormone: a precarious couple for cardiovascular disease
Tomaschitz, A., Ritz, E., Pieske, B., Fahrleitner-Pammer, A., Kienreich, K., Horina, J. H., Drechsler, C., Marz, W., Ofner, M., Pieber, T. R., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs092 · Cited by 132
Asymptomatic Primary Hyperparathyroidism
Silverberg, S. J., Walker, M. D., & Bilezikian, J. P. (2013) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2012.11.005 · Cited by 128
Self-citationParathyroid hormone and the cardiovascular system
Fitzpatrick, L. A., Bilezikian, J. P., & Silverberg, S. J. (2008) · Current Osteoporosis Reports · doi:10.1007/s11914-008-0014-8 · Cited by 117
Self-citationOng, G. S. Y., Walsh, J. P., Stuckey, B. G. A., Brown, S. J., Rossi, E., Ng, J. L., Nguyen, H., Kent, G. N., & Lim, E. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1429 · Cited by 101
“50 nmol/liter 60 (21, 102) 60 (26, 110) 58 (22.”
BackgroundUllah, M. I., Uwaifo, G. I., Nicholas, W. C., & Koch, C. A. (2009) · International Journal of Endocrinology · doi:10.1155/2010/579640 · Cited by 106
“The patients with mild primary HPT have been found to have increased stiffness measured in the radial artery [53].”
BackgroundAsymptomatic primary hyperparathyroidism
Bilezikian, J. P., Rubin, M. R., & Silverberg, S. J. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000400010 · Cited by 95
Self-citationTordjman, K. M., Yaron, M., Izkhakov, E., Osher, E., Shenkerman, G., Marcus-Perlman, Y., & Stern, N. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-1067 · Cited by 94
Brown, J. M., Williams, J. S., Luther, J. M., Garg, R., Garza, A. E., Pojoga, L. H., Ruan, D. T., Williams, G. H., Adler, G. K., & Vaidya, A. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.01910 · Cited by 88
Bandeira, F. A. F., Griz, L., Chaves, N., Crispim, N., Borges, L. M., Lazaretti‐Castro, M., Borba, V. Z. C., Castro, L. C., Borges, J. L. C., & Bilezikian, J. P. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000600002 · Cited by 86
Self-citationLarge-artery stiffness: A reversible marker of cardiovascular risk in primary hyperparathyroidism
Schillaci, G., Pucci, G., Pirro, M., Monacelli, M., Scarponi, A. M., Manfredelli, M. R., Rondelli, F., Avenia, N., & Mannarino, E. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.05.010 · Cited by 90
Osto, E., Fallo, F., Pelizzo, M. R., Maddalozzo, A., Sorgato, N., Corbetti, F., Montisci, R., Famoso, G., Bellu, R., Lüscher, T. F., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.081307 · Cited by 85
Walker, M. D., Rundek, T., Homma, S., DiTullio, M., Iwata, S., Lee, J. A., Choi, J., Liu, R., Zhang, C., McMahon, D. J., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0124 · Cited by 79
Self-citationGondim, C. S. D. S. E., Veras, A., & Bandeira, F. A. F. (2013) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.4137/cmed.s13147 · Cited by 79
McMahon, D. J., Carrelli, A. L., Palmeri, N., Zhang, C. A., Tullio, M. R. D., Silverberg, S. J., & Walker, M. D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3202 · Cited by 79
Self-citationPersson, A., Bollerslev, J., Rosén, T., Mollerup, C., Franco, C., Isaksen, G. A., Ueland, T., Jansson, S. K. G., Caidahl, K., & on behalf of the SIPH Study Group (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03909.x · Cited by 74
Primary Hyperparathyroidism: A Narrative Review of Diagnosis and Medical Management
Dandurand, K., Ali, D. S., & Khan, A. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081604 · Cited by 70
“PHPT appears to be associated with left ventricular hypertrophy [45], aortic valve calcification [48], increased aortic stiffness [49] and increased intimal media thickness [50] which may all contribute to the cardiovascular disease burden seen in PHPT.”
BackgroundEjlsmark-Svensson, H., Rolighed, L., & Rejnmark, L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02456 · Cited by 62
Acute effect of calcium citrate on serum calcium and cardiovascular function
Burt, M. G., Mangelsdorf, B. L., Srivastava, D., & Petersons, C. J. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1761 · Cited by 61
“Contrary to our hypothesis, we found a reduction in median AIx of about 10% following calcium citrate administration, with the change in serum total calcium negatively correlated with the change in AIx.”
ResultInfluentialAhmadieh, H., Kreidieh, O., Akl, E. A., & Fuleihan, G. E. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010787.pub2 · Cited by 77
Nontraditional Manifestations of Primary Hyperparathyroidism
Walker, M. D., Rubin, M. R., & Silverberg, S. J. (2013) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2012.11.008 · Cited by 55
“Indeed, in one study, PHPTwas a stronger predictor of increased aortic stiffness than many traditional cardiovascular risk factors and was associated with the extent of elevation in PTH levels (77).”
Self-citationPulse wave velocity in primary hyperparathyroidism and effect of surgical therapy
Rosa, J., Raška, I., Wichterle, D., Petrák, O., Štrauch, B., Krátká, Z., Zelinka, T., Holaj, R., & Widimsky, J., Jr. (2010) · Hypertension Research · doi:10.1038/hr.2010.232 · Cited by 58
Mineral metabolism and outcomes in chronic kidney disease stage 2–4 patients
Chartsrisak, K., Vipattawat, K., Assanatham, M., Nongnuch, A., Ingsathit, A., Domrongkitchaiporn, S., Sumethkul, V., & Disthabanchong, S. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-14 · Cited by 52
“Serum PTH also correlated with an increase in systolic and diastolic blood pressure, and patients with mild primary hyperparathyroidism exhibited increased arterial stiffness [32,33].”
BackgroundAndrade, J. G., Er, L., Ignaszewski, A. P., & Levin, A. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00900208 · Cited by 52
Cansu, G. B., Yılmaz, N., Özdem, S., Balcı, M. K., Süleymanlar, G., Arıcı, C., Boz, A., Sarı, R., & Altunbaş, H. (2015) · Clinical Endocrinology · doi:10.1111/cen.12952 · Cited by 50
Pirro, M., Manfredelli, M. R., Helou, R. S., Scarponi, A. M., Schillaci, G., Bagaglia, F., Melis, F., & Mannarino, E. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13128 · Cited by 54
Potential pathophysiological role for the vitamin D deficiency in essential hypertension
Carbone, F., Mach, F., Vuilleumier, N., & Montecucco, F. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i5.260 · Cited by 50
Asymptomatic hyperparathyroidism – need for multicentre studies
Mihai, R., Wass, J. A. H., & Sadler, G. P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02970.x · Cited by 44
Christensen, M. H. E., Dankel, S. N., Nordbø, Y., Varhaug, J. E., Almås, B., Lien, E. A., & Mellgren, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020481 · Cited by 47
“In line with this, patients with PHPT were shown to have an increased risk of hypertension [9,10] and impaired glucose tolerance [11].”
BackgroundNilsson, I. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12840 · Cited by 47
Subclinical and asymptomatic parathyroid disease: implications of emerging data
Macfarlane, D. P., Yu, N., & Leese, G. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70083-4 · Cited by 42
Non classical complications of primary hyperparathyroidism
Chiodini, I., Cairoli, E., Palmieri, S., Pepe, J., & Walker, M. D. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.06.006 · Cited by 40
Rydberg, E., Birgander, M., Bondeson, A., Bondeson, L., & Willenheimer, R. B. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.12.027 · Cited by 40
Interactions between adrenal-regulatory and calcium-regulatory hormones in human health
Brown, J. M., & Vaidya, A. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000062 · Cited by 39
“assessed several intermediate cardiovascular phenotypes, including hypertension [51,52] and arterial stiffness, and demonstrated improvement following parathyroidectomy [53,54].”
BackgroundBilezikian, J. P. (2012) · Endocrine Practice · doi:10.4158/ep12166.ra · Cited by 39
Self-citationKepez, A., Harmancı, A., Hazırolan, T., Işıldak, M., Kocabaş, U., Ateş, A. H., Çiftci, O., Tokgözoğlu, L. S., & Gürlek, A. (2008) · International journal of cardiac imaging · doi:10.1007/s10554-008-9369-2 · Cited by 37
“[9] reported increased arterial stiffness in mild pHPT patients by using a non-invasive device as the ‘augmentation index’.”
BackgroundBMD improvements after operation for primary hyperparathyroidism
Rolighed, L., Vestergaard, P., Heickendorff, L., Sikjær, T., Rejnmark, L., Mosekilde, L., & Christiansen, P. (2012) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-012-1026-5 · Cited by 36
Endothelial function in mild primary hyperparathyroidism
Carrelli, A. L., Walker, M. D., Tullio, M. R. D., Homma, S., Zhang, C. A., McMahon, D. J., & Silverberg, S. J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04485.x · Cited by 34
Self-citationBernardi, S., Giudici, F., Barbato, V., Zanatta, L., Grillo, A., & Fabris, B. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab157 · Cited by 34
Ring, M., Farahnak, P., Gustavsson, T., Nilsson, I., Eriksson, M. J., & Caidahl, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039519 · Cited by 35
“augmentation index (AIx), an indirect measure of the endothelial function and arterial stiffness, has been reported to be increased [13,14].”
BackgroundInfluentialPrimary hyperparathyroidism: recent advances
Walker, M. D., & Bilezikian, J. P. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000511 · Cited by 30
Self-citationFisher, A. A., Srikusalanukul, W., Davis, & Smith (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s38856 · Cited by 32
Hypertension, Antihypertensive Medications, and Risk of Incident Primary Hyperparathyroidism
Vaidya, A., Curhan, G. C., Paik, J. M., Kronenberg, H. M., & Taylor, E. N. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1619 · Cited by 29
Cardiovascular Risk in Patients with Primary Hyperparathyroidism
Tournis, S., Makris, K., Cavalier, E., & Trovas, G. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612824999201105165642 · Cited by 31
Streeten, E. A., Munir, K. M., Hines, S., Mohamed, A., Mangano, C., Ryan, K. A., & Post, W. S. (2008) · Endocrine Practice · doi:10.4158/ep.14.2.155 · Cited by 28
Tomaschitz, A., Fahrleitner-Pammer, A., Pieske, B., Verheyen, N., Amrein, K., Ritz, E., Kienreich, K., Horina, J. H., Schmidt, A., Kraigher-Krainer, E., et al. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-19 · Cited by 26
“hypertension as well as increased arterial stiffness [37-40].”
BackgroundCirculating immature osteoprogenitor cells and arterial stiffening in postmenopausal osteoporosis
Pirro, M., Schillaci, G., Mannarino, M. R., Scarponi, A., Manfredelli, M. R., Callarelli, L., Leli, C., Fabbriciani, G., Helou, R. S., Bagaglia, F., et al. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.01.015 · Cited by 27
Liu, M., Sum, M., Cong, E., Colon, I., Bucovsky, M., WILLIAMS, J., Kepley, A. L., Kuo, J. H., Lee, J. A., Lazar, R. M., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01128-0 · Cited by 26
Self-citationAsbach, E., Bekeran, M., König, A., Lang, K., Hanslik, G., Treitl, M., Ladurner, R., Bidlingmaier, M., Beuschlein, F., Quinkler, M., et al. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1027-6472 · Cited by 25
“In patients with primary hyperparathyroidism, cardiovascular morbidity is reduced after parathyroidectomy [39, 41, 42].”
BackgroundKong, S.-K., Tsai, M.-C., Yeh, C.-L., Tsai, Y.-C., Chien, M.-N., Lee, C., & Tsai, W.-H. (2024) · Bone · doi:10.1016/j.bone.2024.117130 · Cited by 30
Atherosclerotic Surrogate Markers in Adults With Down Syndrome: A Case‐Control Study
Parra, P., da Costa, R. J. S., de Asúa, D. R., Moldenhauer, F., & Suárez, C. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12890 · Cited by 27
Cardiovascular consequences of parathyroid disorders in adults
Bollerslev, J., Sjöstedt, E., & Rejnmark, L. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.02.003 · Cited by 27
Underbjerg, L., Sikjær, T., & Rejnmark, L. (2018) · Clinical Endocrinology · doi:10.1111/cen.13927 · Cited by 23
Wetzel, J., Pilz, S., Grübler, M. R., Fahrleitner‐Pammer, A., Dimai, H. P., von Lewinski, D., Kolesnik, E., Perl, S., Trummer, C., Schwetz, V., et al. (2017) · The Journal of Clinical Hypertension · doi:10.1111/jch.13064 · Cited by 22
Parathyroid Gland Function in Primary Aldosteronism
Bekeran, M., Reincke, M., & Asbach, E. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565224 · Cited by 25
BMD improvements after operation for primary hyperparathyroidism
Rolighed, L., Vestergaard, P., Heickendorff, L., Sikjær, T., Rejnmark, L., Mosekilde, L., & Christiansen, P. (2012) · Bone · doi:10.1016/j.bone.2012.02.535 · Cited by 20
Is surgery necessary for ‘mild’ or ‘asymptomatic’ hyperparathyroidism?
Niederle, B., & Wémeau, J.-L. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0277 · Cited by 18
Walker, M. D., Cong, E., Kepley, A. L., Tullio, M. R. D., Rundek, T., Homma, S., Lee, J. A., Liu, R., Young, P., Zhang, C. A., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3523 · Cited by 18
“Participants enrolled from 2005 through 2008 in our prior published series (24) were also included in this analysis if the 25OHD level was available (n 51).”
MethodSelf-citationDural, A. C., Okoh, A. K., Seicean, A., Yiğitbaş, H., Thomas, G., Yazıcı, P., Shoenhagen, P., Doshi, K. B., Halliburton, S. S., & Berber, E. (2015) · Surgery · doi:10.1016/j.surg.2015.07.037 · Cited by 19
Neurologic disorders of mineral metabolism and parathyroid disease
Agrawal, L., Habib, Z. A., & Emanuele, N. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4087-0.00049-8 · Cited by 18
“…valvular calcifications, conduction abnormalities, arrhythmias, left ventricular hypertrophy, and increased aortic stiffness (Piovesan et al., 1999; Rubin et al., 2005; Silverberg et al., 2009; Vázquez-Dı́az et al., 2009), as well as increased carotid intima media thickness (Walker et al., 2009b).”
BackgroundRossi, G. P., & Vanderriele, P. (2017) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_33 · Cited by 17
Concistrè, A., Grillo, A., Torre, G. L., Carretta, R., Fabris, B., Petramala, L., Marinelli, C., Rebellato, A., Fallo, F., & Letizia, C. (2017) · Endocrine · doi:10.1007/s12020-017-1362-x · Cited by 17
Should ‘Mild Primary Hyperparathyroidism’ be reclassified as ‘insidious’: is it time to reconsider?
Macfarlane, D. P., Yu, N., Donnan, P. T., & Leese, G. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04201.x · Cited by 18
Asymptomatic Primary Hyperparathyroidism: a Commentary on the Revised Guidelines
Khan, A. A., Bilezikian, J. P., & Potts, J. T. J. (2009) · Endocrine Practice · doi:10.4158/ep09162.co · Cited by 16
“More recently, Rubin et al (19) have begun to study vascular and cardiovascular aspects of PHPT in asymptomatic patients.”
BackgroundSelf-citationWebb, D. R., Khunti, K., Lacy, P. S., Gray, L. J., Mostafa, S. A., Talbot, D., Williams, B., & Davies, M. J. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328354f385 · Cited by 20
Asymptomatic and mild primary hyperparathyroidism
Macfarlane, D. P., Yu, N., & Leese, G. (2015) · Annales d Endocrinologie · doi:10.1016/j.ando.2015.03.001 · Cited by 15
Li, J., Lai, H. C., Yang, L., Zhu, H., Chen, S., & Lai, S. (2017) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.05.045 · Cited by 15
Maruani, G., Cornière, N., Nicolet, L., Baron, S., Courbebaisse, M., Renaud, S., & Houillier, P. (2012) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.10.369 · Cited by 15
Increased Mortality in Patients with Primary Hyperparathyroidism: Does Surgery Make A Difference?
Collier, A., Ghosh, S. K., Nowell, S., & Clark, D. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0407 · Cited by 14
Amstrup, A. K., & Rejnmark, L. (2024) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2024.103026 · Cited by 14
Jakobsen, N. F. B., Rolighed, L., Nissen, P. H., Mosekilde, L., & Rejnmark, L. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0224 · Cited by 14
Mild primary hyperparathyroidism—to treat or not to treat?
Hassan-Smith, Z. K., Criseno, S., & Gittoes, N. J. L. (2018) · British Medical Bulletin · doi:10.1093/bmb/ldy042 · Cited by 14
Pepe, J., Cipriani, C., Tedeschi, M., Curione, M., Parravano, M., Varano, M., Biamonte, F., Colangelo, L., & Minisola, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-35017-y · Cited by 12
Parathyroid hormone may play a role in the pathophysiology of primary hypertension
Oinonen, L., Tikkakoski, A., Koskela, J., Eräranta, A., Kähönen, M. A. P., Niemelä, O. J., Mustonen, J. T., & Pörsti, I. H. (2020) · Endocrine Connections · doi:10.1530/ec-20-0446 · Cited by 13
“Previous results concerning wave reflection and PTH have been conflicting, showing either unchanged [45,46] or increased AIx patients with primary hyperparathyroidism [17,57].”
ResultPrimary hyperparathyroidism – is mild disease worth treating?
Gittoes, N., & Cooper, M. S. (2010) · Clinical Medicine · doi:10.7861/clinmedicine.10-1-45 · Cited by 12
Primary hyperparathyroidism and vitamin D deficiency
Vélayoudom‐Céphise, F., & Wémeau, J.-L. (2015) · Annales d Endocrinologie · doi:10.1016/j.ando.2015.03.022 · Cited by 10
Cardiorenal syndrome and vitamin D receptor activation in chronic kidney disease
Darabian, S., Rattanasompattikul, M., Hatamizadeh, P., Bunnapradist, S., Budoff, M. J., Kovesdy, C. P., & Kalantar‐Zadeh, K. (2012) · Kidney Research and Clinical Practice · doi:10.1016/j.krcp.2011.12.006 · Cited by 9
“In the line with this, hypertension, impaired glucose tolerance and chronic inflammation have been associated with primary hyperparathyroidism [51–54].”
Cardiovascular Involvement in Primary Hyperparathyroidism
Pepe, J., Minisola, S., Ettorre, E., Desideri, G., & Cipriani, C. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf625 · Cited by 11
Review: New perspectives in the management of primary hyperparathyroidism
Ayuk, J., Cooper, M. S., & Gittoes, N. J. L. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810382326 · Cited by 8
“One study demonstrated that 15% of the variance in the difference between the second and first systolic peaks in the pressure waveform of the radial artery was uniquely accounted for by the presence of PHPT [Rubin et al. 2005].”
BackgroundArterial Stiffness in Thyroid and Parathyroid Disease: A Review of Clinical Studies
Grillo, A., Barbato, V., Antonello, R. M., Cola, M. F., Parati, G., Salvi, P., Fabris, B., & Bernardi, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113146 · Cited by 8
“PTH has been found associated with arterial stiffness in the general population [63,64], and mild pHPT has been found associated with an increase of arterial stiffness, as assessed by AIx [65,66] as well as PWV [67–71], additionally to detrimental effects in other forms of vascular organ involvement as aortic intima-m…”
BackgroundResultThe important players in primary hyperparathyroidism
Bollerslev, J. (2013) · Clinical Endocrinology · doi:10.1111/cen.12291 · Cited by 7
Primary hyperparathyroidism: 7,000 years of progress.
Levine, M. A. (2005) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.72.12.1084 · Cited by 7
Nana, M., Morgan, H., Shrikrishnapalasuriyar, N., & Kalhan, A. (2019) · Journal of Endocrinology and Metabolism · doi:10.14740/jem573 · Cited by 7
Non-traditional Manifestations of Primary Hyperparathyroidism
Walker, M. D., & Silverberg, S. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397166-1.00032-1 · Cited by 6
Self-citationClínica y diagnóstico diferencial de los hiperparatiroidismos
Fernández, C. (2009) · Revista Española de Enfermedades Metabólicas Óseas · doi:10.1016/s1132-8460(09)73461-0 · Cited by 5
Manifestações musculoesqueléticas no hiperparatireoidismo primário
Shinjo, S. K., Pereira, R. M. R., Borssatto, A. G., & Kochen, J. A. L. (2009) · Revista Brasileira de Reumatologia · doi:10.1590/s0482-50042009000600007 · Cited by 5
The Panorama of Hyperparathyroidism
Gupta, K. C., Kumar, C., & Puri, G. (2022) · Indian Journal of Endocrine Surgery and Research · doi:10.5005/jp-journals-10088-11184 · Cited by 4
Metadata
- Authors
- Rubin, M. R., Maurer, M. S., McMahon, D. J., Bilezikian, J. P., & Silverberg, S. J.
- Affiliations
- Columbia University (US)
- Corresponding author
- Silverberg, Shonni J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-06
- Volume
- 90
- Issue
- 6
- Pages
- 3326-3330
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2111131646
- Cited by
- 145
- References
- 36
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 6 · 2020: 6 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 1 · 2015: 9 · 2014: 9 · 2013: 14 · 2012: 20
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK032333, R01DK066329)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- primary hyperparathyroidism, arterial stiffness, augmentation index, cardiovascular risk, parathyroid hormone, bone mineral density, radial artery
- MeSH terms
- Aged, Blood Pressure, Brachial Artery, Female, Heart Rate, Humans, Hyperparathyroidism, Male, Middle Aged, Pulse, Reference Values, Regression Analysis, Systole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.